Tryniski Mark E's Form 4 filing
CONMED CorpCNMD · filed Nov 8, 2021
- Accession no.
- 0001127602-21-028634
- Filed
- Nov 8, 2021
- Trade date
- Nov 5, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions and 4 derivative transactions. Open-market sales total $2.04M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tryniski Mark ECIK 0001242753 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2021 | Common Stock | MOption exerciseAcquired | +4,892 | $51.90 | +$253,894.8 | 13,188 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −4,792 | $156.51F1 | −$749,995.92 | 8,396 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −100 | $157.11 | −$15,711 | 8,296 | Direct | |
| Nov 5, 2021 | Common Stock | MOption exerciseAcquired | +3,399 | $69.03 | +$234,632.97 | 11,695 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −2,899 | $156.44F2 | −$453,519.56 | 8,796 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −500 | $157.06F3 | −$78,530 | 8,296 | Direct | |
| Nov 5, 2021 | Common Stock | MOption exerciseAcquired | +2,886 | $79.94 | +$230,706.84 | 11,182 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −2,386 | $156.44F4 | −$373,265.84 | 8,796 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −500 | $156.95F5 | −$78,475 | 8,296 | Direct | |
| Nov 5, 2021 | Common Stock | MOption exerciseAcquired | +1,843 | $73.94 | +$136,271.42 | 10,139 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −1,743 | $156.48F6 | −$272,744.64 | 8,396 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −100 | $157.05 | −$15,705 | 8,296 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2021 | Common Stock | MOption exerciseDisposed | −4,892 | $0.00 | $0 | 0 | Direct | |
| Nov 5, 2021 | Common Stock | MOption exerciseDisposed | −3,399 | $0.00 | $0 | 0 | Direct | |
| Nov 5, 2021 | Common Stock | MOption exerciseDisposed | −2,886 | $0.00 | $0 | 0 | Direct | |
| Nov 5, 2021 | Common Stock | MOption exerciseDisposed | −1,843 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.